Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay

Clinical and Experimental Immunology

Volumn 108, Issue 2, 1997, Pages 220-226

  Macanovic, M ^a   Lachmann, P J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

deoxyribonuclease; NZB NZW F1 hybrids; radial enzyme diffusion assay; systemic lupus erythematosus

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEOXYRIBONUCLEASE I; DNA ANTIBODY; DOUBLE STRANDED DNA; EDETIC ACID; ENZYME INHIBITOR; G ACTIN; TROMETAMOL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DEGRADATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMURIA; FEMALE; IMMUNODIFFUSION; MOUSE; NEWBORN; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030969852     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.3571249.x     Document Type: Article

References (40)

1. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990; 87:9188-92.
2. Polzar B, Mannherz HG. Nucleotide sequence of a full length cDNA clone encoding the deoxyribonuclease I from the rat parotid gland. Nucleic Acids Res 1990; 18:7151.
3. Peitch MC, Irmler M, French LE, Tschopp J. Genomic organisation and expression of mouse deoxyribonuclease I. Biochem Biophys Res Commun 1995; 207:62-8.
4. Kumick NB. The determination of desoxyribonuclease activity by methyl green: application to serum. Arch Biochem 1950; 29:41-53.
5. Sinicropi D, Baker DL, Prince WS, Sniffer K, Shak S. Colorimetric determination of DNase I activity with a DNA-methyl green substrate. Anal Biochem 1994; 222:351-8.
6. Miyauchi K, Ogawa M, Shibata T, Matsuda K, Mori T, Ito K, Minamiura N, Yamamoto T. Development of a radioimmunoassay for human deoxyribonuclcase I. Clin Chim Acta 1986; 154:115-23.
7. Miyauchi K, Ogawa M, Murata A, Nakano I, Funakoshi A, Mori T. Serum deoxyribonuclease I determined by a radioimmunoassay and an enzymatic assay in malignant diseases. Clin Chim Acta 1989; 184:115-20.
8. Chitrabamrung S, Rubin RL, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1981; 1:55-60.
9. Nadano D, Yasuda T, Kishi K. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin Chem 1993; 39:448-52.
10. Lacks SA. Deoxyribonuclease I in mammalian tissues. J Biol Chem 1981; 256:2644-48.
11. Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. Recombinant human DNAse inhalation in normal subjects and patients with cystic tibrosis. A phase I study. JAMA 1992; 267:1947-51.
12. Gavasto F, Buffa F, Moraini G. Serum deoxyribonuclease I and II in pathologic conditions other than pancreas diseases. Clin Chim Acta 1959; 4:192-6.
13. Kowlessar OD, McEvoy RK. Desoxyribonuclease 1 activity in pancreatic-disease. J Clin Invest 1958; 35:1325-30.
14. Spandidos DA, Ramandanis G, Garas J, Kottaridis SD. Serum deoxyribonucleases in patients with breast cancer. Eur J Cancer 1980; 16:1615-9.
15. Scully C, Spandidos DA, Ward Booth P, McGregor IA, Boyle P. Serum alkaline deoxyribonuclease in oral cancer and premalignant lesions. Biomedicine 1981; 35:179-80.
16. Lykourinas M, Constantinidis C, Spantidos A, Manthopoulos A, Dimopoulos C. The role of acid and alkaline DNases as tumour markers in cancer of the genitourinary tract. Urol Res 1982; 10:67-70.
17. Zollner EJ, Muller WE, Zahn RK. Möglichkeiten zur gezielten Diagnose durch Bestimmung der sauren Desoxyribonucleasen im Urin gesunder Kontrollpersonen und xeroderma pigmentosum-Patienten. Klin Wochenschr 1971; 49:1290-4.
18. Funakoshi A, Wakasugi H, Ibayashi H. Clinical investigation of serum deoxyribonuclease II. Clinical studies of serum deoxyribonuclease activity in pancreatic disease. Gastroenterol Jpn 1979; 14:436-40.
19. 1 hybrid mice. Clin Exp Immunol 1996; 106:243-52.
20. Lachmann PJ. The immunological properties of cell nuclei with special reference to the serological aspects and pathogenesis of systemic lupus erythematosus. PhD thesis. University of Cambridge, 1961.
21. Lachmann PJ. An attempt to characterize the lupus erythematosus cell antigen. Immunology 1961; 4:153-63.
22. Frost PG, Lachmann PJ. The relationship of desoxyribonuclease inhibitor levels in human sera to the occurence of antinuclear antibodies. Clin Exp Immunol 1968; 3:447-55.
23. Hadjiyannaki K, Lachmann PJ. The relation or deoxyribonuclease inhibitor levels to the occurence of antinuclear antibodies in NZB/ NZW mice. Clin Exp Immunol 1972; 11:292-5.
24. Hall AK. Molecular interactions between G-actin. DNase 1 and the beta-thymosins in apoptosis: a hypothesis. Medical Hypotheses 1994: 43:125-31.
25. Peitsch MC, Polzar B, Stephan H, Crompton T, MacDonald HR, Mannherz HG, Tschopp J. Characterization of the endogenous deoxyribonucleases involved in nuclear DNA degradation during apoptosis. EMBO J 1993; 12:371-7.
26. Steinbuch M, Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 1969; 134:279-84.
27. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantification of antigens by single radial immunodiffusion. Immunochemistry 1965; 2:235-54.
28. Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci USA 1974; 71:4742-6.
29. Emlen W, Ansari R, Burdick G. DNA-anti-DNA immune complexes antibody protection of a discrete DNA fragment from DNAase digestion in vitro. Clin Invest 1984; 74:185-90.
30. Puccetti A, Madaio MP, Bellese G, Migliorini P. Anti-DNA antibodies bind to DNase I. J Exp Med 1995; 181:1797-804.
31. Lambert PH, Dixon FJ. Pathogenesis of glomerulonephritis of NZB/ NZW mice. J Exp Med 1968; 127:507-22.
32. Emlen W, Mannik M. Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med 1978; 147:684-99.
33. McCoubrey-Hoyer A, Okarma TB, Holman HR. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med 1984; 77:23-34.
34. Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966; 45:1732-40.
35. Koffler D, Agnello V, Winchester R, Kunkel HG. The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest. 1973; 52:198-204.
36. Sano H, Morimoto C. Isolation of DNA from DNA/anti DNA antibody immune complexes in systemic lupus erythematosus. J Immunol 1981; 126:538-49.
37. Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 1980; 66:1391-9.
38. Steinman CR. Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest 1984; 73:832-41.
39. Kalden JR, Winkler TH, Herrmann M, Krapf F. Pathogenesis of SLE: immunopalhology in man. Rheumatol Int 1991; 11:95-100.
40. Rumore PM, Stainman CR. Endogenous circulating DNA in systemic lupus erythematosus. J Clin Invest 1990; 86:69-74.